TCL Archive NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level March 7, 2014
TCL Archive First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma February 22, 2013
TCL Archive DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer July 9, 1993
